Sensitive thyrotropin and free thyroxine testing in outpatients: Are both necessary?

Archives of Internal Medicine

Volumn 156, Issue 20, 1996, Pages 2333-2337

  Bauer, Douglas C ^a,b   Brown, Andrew N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN; THYROXINE;

ARTICLE; COST BENEFIT ANALYSIS; DIAGNOSTIC VALUE; FREE THYROXINE INDEX; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; THYROID FUNCTION; THYROID FUNCTION TEST; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

ADULT; AGED; AMBULATORY CARE; BIAS (EPIDEMIOLOGY); HUMANS; MASS SCREENING; MEDICAL AUDIT; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; THYROID DISEASES; THYROTROPIN; THYROXINE;

EID: 0029960360     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.156.20.2333     Document Type: Article

References (27)

1. Luxton A. Report of the Working Party on Testing Strategies in Thyroid Disease. Toronto, Ontario: Ontario Ministry of Health Task Force on the Use and Provision of Medical Services; 1992.
2. Hay ID, Bayer MF, Kaplan MM, Klee GG, Larsen PR, Spencer CA. American Thyroid Association assessment of current free thyroid hormone and thyrotropin measurements and guidelines for future clinical assays. Clin Chem. 1991; 37:2002-2008.
3. Ekins R. Measurement of free hormones in blood. Endocr Rev. 1990;11:5-46.
4. Nicoloff JT, Spencer CA. Clinical review 12: the use and misuse of the sensitive assays. J Clin Endocrinol Metab. 1990;71:553-558.
5. Klee GG, Hay ID. Biochemical thyroid function testing. Mayo Clin Proc. 1994; 69:469-470.
6. Ross DS, Daniels GH, Gouveia D. The use and limitations of a chemiluminescent thyrotropin assay as a single thyroid function test in an out-patient endocrine clinic. J Clin Endocrinol Metab. 1990;71:764-769.
7. Caldwell G, Kellett HA, Gow SM, et al. A new strategy for thyroid function testing, Lancet. 1985;1:1117-1119.
8. Sawin CT, Geller A, Kaplan MM, Bacharach P, Wilson PW, Hershman JM. Low serum thyrotropin (thyroid-stimulating hormone) in older persons without hyperthyroidism. Arch Intern Med. 1991;151:165-168.
9. Spencer C, Schwarzbein D, Guttler R, LoPresti J, Nicoloff J. Thyrotropin (TSH)-releasing hormone stimulation test responses employing third and fourth generation TSH assays. J Clin Endocrinol Metab. 1992;76:494-498.
10. Helfand M, Crapo LM. Screening for thyroid disease. Ann Intern Med. 1990; 112:840-849.
11. Ericsson UB, Fernlund P, Thorell JI. Evaluation of the usefulness of a sensitive immunoradiometric assay for thyroid stimulating hormone as a first-line thyroid function test in an unselected patient population. Scand J Clin Lab Invest 1987;47:215-221.
12. Keiding NR, Eskjaer JS, Weeke J, Mabeck CE. The role of thyroid tests in handling of patients in general practice: a phenomenologic study. Scand J Clin Lab Invest Suppl. 1990;200:6-9.
13. Becker DV, Bigos ST, Gaitan E, et al. Optimal use of blood tests for assessment of thyroid function. JAMA. 1993;269:2736-2737.
14. Surks Ml, Chopra IJ, Mariash CN, Nicoloff JT, Solomon DH. American Thyroid Association guidelines for use of laboratory tests in thyroid disorders. JAMA. 1990;263:1529-1532.
15. Ehrmann DA, Weinberg M, Same DH. Limitations to the use of a sensitive assay for serum thyrotropin in the assessment of thyroid status. Arch Intern Med. 1989;149:369-372.
16. Ehrmann DA, Same DH. Serum thyrotropin and the assessment of thyroid status. Ann Intern Med. 1989;110:179-181.
17. Helfand M, Crapo L. Testing for suspected thyroid disease. In: Sox H, ed. Common Diagnostic Tests. 2nd ed. Philadelphia, Pa: American College of Physicians; 1990:148-183.
18. Newman TB, Brown A, Easterling MJ. Obstacles and approaches to clinical database research: experience at the University of California, San Francisco. Proc Annu Symp Comput Appl Med Care. 1994:568-572.
19. Nuutila P, Irjala K, Viikari J, Prinssi VP, Kaihola HL. Comparative evaluation of serum thyroxine, free thyroxine and thyrotropin determinations in screening of thyroid function. Ann Clin Res. 1988;20:158-163.
20. Cooper D, Halpern R, Wood L, Levin A, Ridgway E. L-thyroxine therapy in subclinical hypothyroidism. Ann Intern Med. 1984;101:18-24.
21. Nystrom E, Caidahl K, Fager G, Wikkelso C, Lundberg P, Lindstedt G. A double-blind cross-over 12-month study of L-thyroxine treatment of women with 'subclinical' hypothyroidism. Clin Endocrinol. 1988;29:63-76.
22. Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med. 1994;331: 1249-1252.
23. Ross DS. Bone density is not reduced during the short-term administration of levothyroxine to postmenopausal women with subclinical hypothyroidism: a randomized, prospective study. Am J Med. 1993;95:385-388.
24. Ross DS, Neer RM, Ridgway EC, Daniels GH. Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-thyroxine. Am J Med. 1987;87:1167-1170.
25. Kung AW, Lorentz T, Tam SC. Thyroxine suppressive therapy decreases bone mineral density in post-menopausal women. Clin Endocrinol. 1993;39:535-540.
26. Foldes J, Tarjan G, Szathmari M, Varga F, Krasznai I, Horvath C. Bone mineral density in patients with endogenous subclinical hyperthyroidism: is this thyroid status a risk factor for osteoporosis? Clin Endocrinol. 1993;39:521-527.
27. Bauer D, Ettinger B, Nevitt M, Stone K, Cummings S. Women with low TSH have an increased risk of hip and vertebral fractures: a prospective study. J Bone Miner Res. 1995;10(suppl 1 ):S470. Abstract.